chr5-150297715-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_001012301.4(ARSI):c.1209C>G(p.Ser403Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00218 in 1,613,342 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0018 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0022 ( 10 hom. )
Consequence
ARSI
NM_001012301.4 synonymous
NM_001012301.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0460
Publications
2 publications found
Genes affected
ARSI (HGNC:32521): (arylsulfatase family member I) This gene encodes a protein that belongs to a large family of sulfatases that hydrolyze sulfate esters and sulfamates. Members of this family play a role in several cellular processes, including hormone synthesis, cell signaling in development and degradation of macromolecules. The protein encoded by this gene is thought to be secreted, and to function in extracellular space. [provided by RefSeq, Jul 2016]
ARSI Gene-Disease associations (from GenCC):
- autosomal recessive spastic paraplegia type 66Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 5-150297715-G-C is Benign according to our data. Variant chr5-150297715-G-C is described in ClinVar as Benign. ClinVar VariationId is 465193.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.046 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ARSI | NM_001012301.4 | c.1209C>G | p.Ser403Ser | synonymous_variant | Exon 2 of 2 | ENST00000328668.8 | NP_001012301.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00176 AC: 268AN: 152260Hom.: 2 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
268
AN:
152260
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00196 AC: 490AN: 250042 AF XY: 0.00227 show subpopulations
GnomAD2 exomes
AF:
AC:
490
AN:
250042
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00222 AC: 3244AN: 1460964Hom.: 10 Cov.: 29 AF XY: 0.00227 AC XY: 1653AN XY: 726762 show subpopulations
GnomAD4 exome
AF:
AC:
3244
AN:
1460964
Hom.:
Cov.:
29
AF XY:
AC XY:
1653
AN XY:
726762
show subpopulations
African (AFR)
AF:
AC:
5
AN:
33478
American (AMR)
AF:
AC:
20
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
AC:
3
AN:
26128
East Asian (EAS)
AF:
AC:
0
AN:
39700
South Asian (SAS)
AF:
AC:
326
AN:
86208
European-Finnish (FIN)
AF:
AC:
104
AN:
52606
Middle Eastern (MID)
AF:
AC:
3
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
2675
AN:
1111974
Other (OTH)
AF:
AC:
108
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
222
444
667
889
1111
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
98
196
294
392
490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00176 AC: 268AN: 152378Hom.: 2 Cov.: 32 AF XY: 0.00148 AC XY: 110AN XY: 74516 show subpopulations
GnomAD4 genome
AF:
AC:
268
AN:
152378
Hom.:
Cov.:
32
AF XY:
AC XY:
110
AN XY:
74516
show subpopulations
African (AFR)
AF:
AC:
13
AN:
41602
American (AMR)
AF:
AC:
14
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
1
AN:
5174
South Asian (SAS)
AF:
AC:
21
AN:
4832
European-Finnish (FIN)
AF:
AC:
17
AN:
10628
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
165
AN:
68040
Other (OTH)
AF:
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
13
25
38
50
63
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
5
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Spastic paraplegia Benign:1
Jul 17, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.